BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35438389)

  • 1. Current Approaches in Hepatoblastoma-New Biological Insights to Inform Therapy.
    Wu PV; Rangaswami A
    Curr Oncol Rep; 2022 Sep; 24(9):1209-1218. PubMed ID: 35438389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future management strategies for relapsed or progressive hepatoblastoma.
    Venkatramani R; Furman WL; Fuchs J; Warmann SW; Malogolowkin MH
    Paediatr Drugs; 2012 Aug; 14(4):221-32. PubMed ID: 22702740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer.
    Hirsch TZ; Pilet J; Morcrette G; Roehrig A; Monteiro BJE; Molina L; Bayard Q; Trépo E; Meunier L; Caruso S; Renault V; Deleuze JF; Fresneau B; Chardot C; Gonzales E; Jacquemin E; Guerin F; Fabre M; Aerts I; Taque S; Laithier V; Branchereau S; Guettier C; Brugières L; Rebouissou S; Letouzé E; Zucman-Rossi J
    Cancer Discov; 2021 Oct; 11(10):2524-2543. PubMed ID: 33893148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT).
    Hiyama E; Ueda Y; Onitake Y; Kurihara S; Watanabe K; Hishiki T; Tajiri T; Ida K; Yano M; Kondo S; Oue T;
    Pediatr Surg Int; 2013 Oct; 29(10):1071-5. PubMed ID: 24026876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery for hepatoblastoma in children.
    Geiger JD
    Curr Opin Pediatr; 1996 Jun; 8(3):276-82. PubMed ID: 8814407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance in hepatoblastoma.
    Warmann SW; Fuchs J
    Curr Pharm Biotechnol; 2007 Apr; 8(2):93-7. PubMed ID: 17430157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose modifications and pharmacokinetics of adjuvant cisplatin monotherapy while on hemodialysis for patients with hepatoblastoma.
    Boucher AA; Mizuno T; Vinks AA; Goldstein SL; Tiao GM; Geller JI
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27425. PubMed ID: 30160353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
    Fuchs J; Wenderoth M; von Schweinitz D; Haindl J; Leuschner I
    Cancer; 1998 Dec; 83(11):2400-7. PubMed ID: 9840541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Innovations for Targeting Hepatoblastoma.
    Garnier A; Ilmer M; Kappler R; Berger M
    Anticancer Res; 2016 Nov; 36(11):5577-5592. PubMed ID: 27793881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.
    Marayati R; Stafman LL; Williams AP; Bownes LV; Quinn CH; Aye JM; Stewart JE; Yoon KJ; Anderson JC; Willey CD; Beierle EA
    Sci Rep; 2021 Mar; 11(1):5984. PubMed ID: 33727604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
    Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
    Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of hepatoblastoma in the Indian context.
    Arora RS
    Indian Pediatr; 2012 Apr; 49(4):307-9. PubMed ID: 22080621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
    Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic blastomatous tumor in a child responding to therapy used for hepatoblastoma: case report and review of the literature.
    Morgan ER; Perryman JH; Reynolds M; Gonzalez-Crussi FJ
    Med Pediatr Oncol; 1996 Apr; 26(4):284-92. PubMed ID: 8600344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
    Ortega JA; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Finegold MJ; Haas JE; King DR; Liu-Mares W; Sensel MG; Krailo MD
    J Clin Oncol; 2000 Jul; 18(14):2665-75. PubMed ID: 10894865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hepatoblastoma with high-dose chemotherapy and stem cell rescue: the pediatric blood and marrow transplant consortium experience and review of the literature.
    Karski EE; Dvorak CC; Leung W; Miller W; Shaw PJ; Qayed M; Katsanis E; Feusner JH
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):362-8. PubMed ID: 24577552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoresistant hepatoblastoma in a patient with mosaic trisomy 18 treated with orthotopic liver transplantation.
    Fernandez KS; Baum R; Fung B; Yeager N; Leonis MA; Wagner LM; Tiao G; Ross ME
    Pediatr Blood Cancer; 2011 Mar; 56(3):498-500. PubMed ID: 21113936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
    Natarajan E; Auerbach C; Cheron R; Pashankar F
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e659-e661. PubMed ID: 31259823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor.
    Sasaki F; Matsunaga T; Iwafuchi M; Hayashi Y; Ohkawa H; Ohira M; Okamatsu T; Sugito T; Tsuchida Y; Toyosaka A; Nagahara N; Nishihira H; Hata Y; Uchino J; Misugi K; Ohnuma N;
    J Pediatr Surg; 2002 Jun; 37(6):851-6. PubMed ID: 12037748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.